Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Regulation of Endogenous Glucose Production by Brain Insulin Action in Insulin Resistance
NCT03383822Phase 2Completed
- Sponsor
- University Health Network
- Start
- Sep 2015
- Primary completion
- Jul 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of Generex Oral-lyn in insulin resistance (IR), sponsored by University Health Network. Started Sep 2015; status: completed.
02
Drugs
Generex Oral-lyn
03
Conditions
insulin resistance (IR)
Beyond the preview
Go deeper on NCT03383822.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03383822.